Tag: telemedicine

KRIs, KPIs and Dashboards to Monitor Telemedicine & Virtual Visits Performance KRIs, KPIs and Dashboards to Monitor Telemedicine & Virtual Visits Performance As decentralized and hybrid clinical trials continue to grow in significance, the integration of telemedicine and virtual visits into clinical research frameworks has become paramount. Monitoring these innovative approaches necessitates the establishment of…

Read More “KRIs, KPIs and Dashboards to Monitor Telemedicine & Virtual Visits Performance” »

Case Studies: Telemedicine & Virtual Visits That Improved Recruitment and Retention Case Studies: Telemedicine & Virtual Visits That Improved Recruitment and Retention In the evolving landscape of clinical trials, particularly in the context of decentralized and hybrid models, telemedicine and virtual visits have emerged as key methods to enhance patient recruitment and retention. This article…

Read More “Case Studies: Telemedicine & Virtual Visits That Improved Recruitment and Retention” »

<!– –> Patient-Centric Design Principles for Successful Telemedicine & Virtual Visits Patient-Centric Design Principles for Successful Telemedicine & Virtual Visits Introduction to Patient-Centric Design in Clinical Trials As the clinical trial landscape continues to evolve with advancements in technology, there has been a significant shift towards decentralized and hybrid clinical trials. The integration of telemedicine…

Read More “Patient-Centric Design Principles for Successful Telemedicine & Virtual Visits” »

Telemedicine & Virtual Visits: Operating Blueprint for Scalable Decentralized Trials Telemedicine & Virtual Visits: Operating Blueprint for Scalable Decentralized Trials Introduction to Decentralized Clinical Trials Decentralized clinical trials (DCTs) are emerging as a transformative approach in modern clinical research, driven by advancements in technology and the necessity for patient-centric methodologies. DCTs leverage telemedicine, remote monitoring,…

Read More “Telemedicine & Virtual Visits: Operating Blueprint for Scalable Decentralized Trials” »

How to Design Telemedicine & Virtual Visits That Meets FDA, EMA and MHRA Expectations How to Design Telemedicine & Virtual Visits That Meets FDA, EMA and MHRA Expectations The paradigm of clinical trials is continually evolving, particularly with the rise of decentralized and hybrid clinical trials that incorporate telemedicine and virtual visit strategies. As regulatory…

Read More “How to Design Telemedicine & Virtual Visits That Meets FDA, EMA and MHRA Expectations” »

Telemedicine & Virtual Visits in Practice: Step-by-Step Guide for Sponsors and CROs The integration of telemedicine and virtual visits into clinical trials represents a significant advancement in the clinical research landscape. As trials become increasingly decentralized, understanding how to effectively implement these strategies is crucial for sponsors, contract research organizations (CROs), and site management organizations…

Read More “Telemedicine & Virtual Visits in Practice: Step-by-Step Guide for Sponsors and CROs” »

Common Pitfalls in Telemedicine & Virtual Visits—and How to Avoid Compliance Risks Common Pitfalls in Telemedicine & Virtual Visits—and How to Avoid Compliance Risks The clinical research landscape is rapidly evolving, particularly with the advent of decentralized and hybrid clinical trials. Telemedicine and virtual visits offer significant benefits but also present unique compliance risks. This…

Read More “Common Pitfalls in Telemedicine & Virtual Visits—and How to Avoid Compliance Risks” »

Aligning Telemedicine & Virtual Visits With GCP, Telehealth and Home-Based Care Regulations In recent years, the integration of telemedicine and virtual visits into clinical trials has revolutionized the landscape of clinical research. Given the necessity for compliance with Good Clinical Practice (GCP) and varying regulatory frameworks across the US, UK, and EU, it is essential…

Read More “Aligning Telemedicine & Virtual Visits With GCP, Telehealth and Home-Based Care Regulations” »